Tenders of Aok Rheinland Pfalz Saarland Die Gesundheitskasse

Tenders of Aok Rheinland Pfalz Saarland Die Gesundheitskasse

AOK Rheinland Pfalz Saarland Die Gesundheitskasse Tender

Germany
Closing Date30 Nov 2025
Tender AmountRefer Documents 
Conclusion of non-exclusive discount agreements in accordance with Sections 130a Paragraph 8/130c Paragraph 1 SGB V for medicinal products with the active ingredient fusidic acid (d06ax01) as part of a so-called open-house model.

AOK Rheinland Pfalz Saarland Die Gesundheitskasse Tender

Germany
Closing Date30 Nov 2025
Tender AmountRefer Documents 
Germany-eisenberg: Pharmaceutical Products

AOK Rheinland Pfalz Saarland Die Gesundheitskasse Tender

Germany
Closing Date30 Nov 2025
Tender AmountRefer Documents 
Germany-eisenberg: Pharmaceutical Products

AOK Rheinland Pfalz Saarland Die Gesundheitskasse Tender

Germany
Closing Date30 Nov 2025
Tender AmountRefer Documents 
Conclusion of non-exclusive discount agreements in accordance with Sections 130a Paragraph 8/130c Paragraph 1 SGB V for medicinal products with the active ingredient Ambrisentan (c02kx02) within the framework of a so-called open-house model.

AOK Rheinland Pfalz Saarland Die Gesundheitskasse Tender

Germany
Closing Date30 Nov 2025
Tender AmountRefer Documents 
Germany-eisenberg: Pharmaceutical Products

AOK Rheinland Pfalz Saarland Die Gesundheitskasse Tender

Germany
Closing Date30 Nov 2025
Tender AmountRefer Documents 
Conclusion of non-exclusive discount agreements in accordance with Sections 130a Paragraph 8/130c Paragraph 1 SGB V for medicinal products with the active ingredient Sevelamer hydrochloride (v03ae02) within the framework of a so-called open-house model.

AOK Rheinland Pfalz Saarland Die Gesundheitskasse Tender

Germany
Closing Date30 Nov 2025
Tender AmountRefer Documents 
Germany-eisenberg: Pharmaceutical Products

AOK Rheinland Pfalz Saarland Die Gesundheitskasse Tender

Germany
Closing Date30 Nov 2025
Tender AmountRefer Documents 
Conclusion of non-exclusive discount agreements in accordance with Sections 130a Paragraph 8/130c Paragraph 1 SGB V for medicinal products with the active ingredient Methoxy-polyethylene glycol-epoetin Beta (b03xa03 (open-house model)

AOK Rheinland Pfalz Saarland Die Gesundheitskasse Tender

Germany
Closing Date30 Nov 2025
Tender AmountRefer Documents 
Germany-eisenberg: Pharmaceutical Products

AOK Rheinland Pfalz Saarland Die Gesundheitskasse Tender

Germany
Closing Date30 Nov 2025
Tender AmountRefer Documents 
Germany-eisenberg: Pharmaceutical Products
161-170 of 261 active Tenders